Vmbook Online ordering

Atrion Corp

Atrion Corporation (ATRI) is a public company traded on the NASDAQ stock exchange. It is a small-cap company with a market capitalization of around $1.5 billion as of February 2023.

ATRI operates in the manufacturing and sale of oem (original equipment manufacturer) components and medical devices. Its products are used in a variety of applications, including medical, aerospace, and industrial.

In terms of financials, Atrion has consistently delivered solid earnings over the past few years. For the full year 2022, the company reported net sales of $145.4 million, representing an increase of 3.9% compared to the prior year. Net income for the year was $32.4 million, or $5.83 per diluted share, compared to $29.3 million, or $5.13 per diluted share, in the prior year.

Looking at Atrion's earnings growth, the company has consistently delivered earnings per share (EPS) growth over the past five years. From 2017 to 2022, Atrion's EPS has grown at a compound annual growth rate (CAGR) of approximately 12%.

As for its price-to-earnings (P/E) ratio, Atrion currently trades at a trailing twelve-month P/E ratio of around 23.3x, which is slightly above the industry average.

It is important to note that past performance is not indicative of future results and investing in the stock market always carries risks. It is always recommended to conduct your own research or consult with a financial advisor before making any investment decisions.